WallStreetZenWallStreetZen

NASDAQ: ONCY
Oncolytics Biotech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ONCY

Based on 2 analysts offering 12 month price targets for Oncolytics Biotech Inc.
Min Forecast
$3.00+154.24%
Avg Forecast
$4.00+238.98%
Max Forecast
$5.00+323.73%

Should I buy or sell ONCY stock?

Based on 2 analysts offering ratings for Oncolytics Biotech Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ONCY stock forecasts and price targets.

ONCY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-04
lockedlocked$00.00+00.00%2024-03-08

1 of 1

Forecast return on equity

Is ONCY forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.04%

Forecast return on assets

Is ONCY forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ONCY revenue forecast

What is ONCY's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$13.9M
Avg 2 year Forecast
$77.1M
Avg 3 year Forecast
$303.8M

ONCY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ONCY$1.18$4.00+238.98%Buy
JAGX$0.32N/AN/A
HOOK$0.88$5.00+468.18%Buy
BYSI$2.28N/AN/A
CNTB$1.57$8.00+409.55%Buy
View Top Biotech Stocks

Oncolytics Biotech Stock Forecast FAQ

Is Oncolytics Biotech Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ONCY) stock is to Buy ONCY stock.

Out of 2 analysts, 0 (0%) are recommending ONCY as a Strong Buy, 2 (100%) are recommending ONCY as a Buy, 0 (0%) are recommending ONCY as a Hold, 0 (0%) are recommending ONCY as a Sell, and 0 (0%) are recommending ONCY as a Strong Sell.

If you're new to stock investing, here's how to buy Oncolytics Biotech stock.

What is ONCY's revenue growth forecast for 2026-2028?

(NASDAQ: ONCY) Oncolytics Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.8%.

Oncolytics Biotech's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ONCY's revenue for 2026 to be $1,033,004,565, with the lowest ONCY revenue forecast at $1,033,004,565, and the highest ONCY revenue forecast at $1,033,004,565. On average, 1 Wall Street analysts forecast ONCY's revenue for 2027 to be $5,738,831,556, with the lowest ONCY revenue forecast at $5,738,831,556, and the highest ONCY revenue forecast at $5,738,831,556.

In 2028, ONCY is forecast to generate $22,607,766,329 in revenue, with the lowest revenue forecast at $22,607,766,329 and the highest revenue forecast at $22,607,766,329.

What is ONCY's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ONCY) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ONCY's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ONCY price target, the average ONCY price target is $4.00, with the highest ONCY stock price forecast at $5.00 and the lowest ONCY stock price forecast at $3.00.

On average, Wall Street analysts predict that Oncolytics Biotech's share price could reach $4.00 by Apr 4, 2025. The average Oncolytics Biotech stock price prediction forecasts a potential upside of 238.98% from the current ONCY share price of $1.18.

What is ONCY's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ONCY) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.